103 related articles for article (PubMed ID: 17255751)
1. Truvada intolerance.
Vemuri S; Bratberg J; Burke K; Skowron G
AIDS; 2007 Jan; 21(3):382-3. PubMed ID: 17255751
[No Abstract] [Full Text] [Related]
2. A truvada hypersensitivity reaction simulating abacavir hypersensitivity.
de Perio MA; Gomez FJ; Frame PT; Fichtenbaum CJ
AIDS; 2007 Oct; 21(16):2252-3. PubMed ID: 18090057
[No Abstract] [Full Text] [Related]
3. Two-once-daily fixed-dose NRTI combinations for HIV.
Med Lett Drugs Ther; 2005 Feb; 47(1203):19-20. PubMed ID: 15767973
[TBL] [Abstract][Full Text] [Related]
4. [Simply convincing. New fixed combination for HIV therapy].
MMW Fortschr Med; 2005 Apr; 147 Spec No 1():20-3. PubMed ID: 16385865
[No Abstract] [Full Text] [Related]
5. Emtricitabine/tenofovir (Truvada) for HIV prophylaxis.
Coutinho B; Prasad R
Am Fam Physician; 2013 Oct; 88(8):535-40. PubMed ID: 24364575
[No Abstract] [Full Text] [Related]
6. Switching Combivir to Truvada keeps HIV undetectable, improves blood fats, fails to improve limb fat.
Proj Inf Perspect; 2008 Dec; (47):8. PubMed ID: 19227559
[No Abstract] [Full Text] [Related]
7. Generic Truvada approved.
AIDS Patient Care STDS; 2009 May; 23(5):395. PubMed ID: 19422066
[No Abstract] [Full Text] [Related]
8. Using registries to monitor HIV pre-exposure prophylaxis safety in clinical settings.
Tilson HH
Am J Prev Med; 2013 Jan; 44(1 Suppl 2):S151-5. PubMed ID: 23253758
[No Abstract] [Full Text] [Related]
9. Bioequivalent formulation for the fixed-dose regimen of Truvada and TMC278 finalized.
AIDS Patient Care STDS; 2010 Jun; 24(6):395-6. PubMed ID: 20575158
[No Abstract] [Full Text] [Related]
10. The Truvada wars.
Belluz J
BMJ; 2014 Jun; 348():g3811. PubMed ID: 24961949
[No Abstract] [Full Text] [Related]
11. Truvada and Epivir are similar at suppressing HIV.
Proj Inf Perspect; 2009 Mar; (48):5-6. PubMed ID: 19492457
[No Abstract] [Full Text] [Related]
12. Transmission. Company halts Truvada PrEP for women study.
AIDS Policy Law; 2011 Jun; 26(7):1. PubMed ID: 21735622
[No Abstract] [Full Text] [Related]
13. [New fixed combination for HIV therapy].
Krankenpfl J; 2005; 43(4-6):95. PubMed ID: 16171046
[No Abstract] [Full Text] [Related]
14. New once-a-day drugs: Truvada and Epzicom.
Berger DS
Posit Aware; 2004; 15(6):38-9. PubMed ID: 15619773
[No Abstract] [Full Text] [Related]
15. South Africa to tighten control on drug trials after five death.
Sidley P
BMJ; 2000 Apr; 320(7241):1028. PubMed ID: 10764354
[No Abstract] [Full Text] [Related]
16. AIDS research. Complexity surrounds HIV prevention advances.
Cohen J
Science; 2011 Jul; 333(6041):393. PubMed ID: 21778370
[No Abstract] [Full Text] [Related]
17. FDA PrEPares to reduce risk of HIV infection with Truvada®.
Breeze S
Expert Rev Clin Pharmacol; 2012 Sep; 5(5):499. PubMed ID: 23272332
[No Abstract] [Full Text] [Related]
18. In brief: Truvada for HIV prevention.
Med Lett Drugs Ther; 2012 Aug; 54(1396):63-4. PubMed ID: 22869292
[No Abstract] [Full Text] [Related]
19. HIV/AIDS clinical trials. A powerful and perplexing new HIV prevention tool.
Cohen J
Science; 2010 Dec; 330(6009):1298-9. PubMed ID: 21127220
[No Abstract] [Full Text] [Related]
20. Minor emtricitabine intolerance in treatment-stable patients switched from tenofovir/lamivudine to a fixed-dose combination of tenofovir/emtricitabine (Truvada).
Palacios R; Terrón A; Hidalgo A; Rivero A; Santos J;
J Antimicrob Chemother; 2008 Feb; 61(2):462-3. PubMed ID: 18156608
[No Abstract] [Full Text] [Related]
[Next] [New Search]
